glp-1/gip vs tirzepatide GLP-1 Medications for Weight Loss: Semaglutide vs Retat – Revolution Health & Wellness Structures of (a) GLP-1, (b)

Shannon Brooks, 29, never thought shed find herself standing in her South Side Chicago kitchen every Sunday night, mixing vials to create her own weight-loss drugs

According to the STEP 1 trial published in the New England Journal of Medicine, patients taking semaglutide 2.4 mg (Wegovy) achieved approximately: 3% to 5% body weight loss by week 12 10% to 12% body weight loss by week 28 15% to 17% body weight loss by week 68 (maximum effect) These figures represent average outcomes in clinical trials

Possible confounders There is evidence that smoking, sex, and body mass index (BMI) are linked to leukocyte telomere length, i.e., smokers 52 , males 53 , and high BMI 54 are associated with shorter telomeres

If your primary goal is B12 repletion, oral is a reasonable alternative